In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of
PASSIGE: A new gene editing technique combines prime editing and evolved recombinases for precise, efficient integration of large genes, advancing gene therapy potential.
In today’s fast-paced world, finding nutritious snacks that can keep up with our busy lives is essential. High-protein snacks are an excellent choice, providing